REMINDER: FDA Webinar - Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptibility Test Devices, February 12, 2019

REMINDER: FDA Webinar - Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptibility Test Devices, February 12, 2019

Tomorrow, February 12, 2019 from 3:00 – 4:30 PM Eastern the U.S. Food and Drug Administration (FDA) will host a webinar on the final guidance, Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptibility Test Devices. The goal of this guidance is to minimize time between the approval of new antimicrobial drugs and clearance of antimicrobial susceptibility tests for those drugs and to provide recommendations to the medical device and drug industry on how to work together to facilitate timely antimicrobial susceptibility test device clearance by the FDA. This final guidance supports the FDA’s strategic approach for combatting antimicrobial resistance to better coordinate drug and device development, promote stewardship, support antimicrobial resistance surveillance and advance regulatory science.

Webinar Details:

Date: Tuesday, February 12, 2019

Time: 3:00 – 4:30 PM Eastern Time

To ensure you are connected, please dial-in 15 minutes prior to the start of the webinar.

NOTE: You must dial-in to hear the presentation and ask questions:

U.S. Callers Dial: 888-790-2044

CONFERENCE NUMBER: PWXW8485677, PASSCODE: 9510725

International Callers Dial: 1-312-470-7375

CONFERENCE NUMBER: PWXW8485677, PASSCODE: 9510725

To view the slide presentation during the webinar:

https://www.mymeetings.com/nc/join.php?i=PWXW8485677&p=9510725&t=c

Following the webinar, a transcript, audio recording, and slides will be available at:http://www.fda.gov/CDRHWebinar.

We appreciate your feedback on our webinar program. Following the webinar, we will provide a link to a short survey about your FDA CDRH webinar experience, which should take no more than 5-10 minutes to complete. Your responses are confidential and will be used to help ensure the quality of our webinar program.

NOTE: The FDA does not provide Continuing Education (CEU) or Certificates of Attendance for webinar attendance.

Target Audience: Industry

If you have any questions, please contact CDRH's Division of Industry and Consumer Education (DICE) at DICE@fda.hhs.gov, or by phone at 1-800-638-2041, or 301-796-7100.